Temperature: dry vs. reconstituted
Reconstitution — dissolving a lyophilized peptide into a liquid — trades the stability of a dry solid for the convenience of a solution. Once in solution, degradation pathways that are essentially frozen in the dry state (hydrolysis in particular) become active again. The table below reflects general principles from the pharmaceutical stability literature, not a specific product claim.
| Storage condition | Dry (lyophilized) powder | Reconstituted (in solution) |
|---|---|---|
| Room temperature | Least stable of the dry-storage options; acceptable only briefly for materials without other guidance | Least stable option by far — solution-phase degradation accelerates significantly at room temperature |
| Refrigerated (~2–8°C) | Improved stability over room temperature for most dry peptides | The standard recommendation once reconstituted, to slow ongoing degradation — but still time-limited, not indefinite |
| Frozen (below 0°C) | Generally the most stable long-term storage condition for dry material | Freeze–thaw cycling can itself damage some peptides via aggregation; not automatically safer than refrigeration for a solution |
The general rule worth remembering: a reconstituted solution is always less stable than the same material in its dry form, regardless of temperature. Exactly how long a specific reconstituted solution remains usable for a given research protocol depends on that protocol, the diluent used, and the specific peptide — not something a general guide can respond with a single number for. This page intentionally does not provide a specific "good for X days" deadline for prepared material; that determination belongs to the documented research protocol being followed.
Light and air exposure
- Use amber or opaque containers. Some peptide structures are susceptible to light-driven degradation; amber glass or an opaque outer container reduces UV and visible-light exposure during storage.
- Minimize time a container sits open. Every moment a vial is uncapped is an opportunity for moisture and airborne contaminants to enter — reseal promptly.
- Follow standard aseptic laboratory technique when opening a sealed vial. Disinfect access points before opening and use single-use sterile transfer equipment appropriate to the analytical protocol being followed, to prevent contaminating the sample. Institutions should defer to their own lab's standard operating procedures for aseptic sample handling rather than this general page.
- Treat a vial's sterility as compromised once accessed. After a sealed vial has been opened and sample withdrawn for analysis, its remaining contents should not be treated as still sealed-sterile on the original timeline.
What this page does not establish
This page describes general stability and handling principles drawn from published pharmaceutical literature. It is not a stability claim or handling instruction for any specific DAAVY Research listing or lot, and it does not provide reconstitution volumes, diluent recommendations, dosing information, or a specific usage deadline for prepared material. Storage conditions applicable to a specific product should be confirmed against that product's label and current Certificate of Analysis — see our full storage and handling guide for the underlying detail on temperature, moisture, and container practices for material in its dry form.